Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI help surgeons see thyroid cancer more clearly?

NCT ID NCT06498674

Diagnosis Sponsor: Fujian Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial is testing whether an AI-assisted ultrasound system can help surgeons plan thyroid cancer surgery. People scheduled for thyroid surgery will receive a standard ultrasound followed by an AI-assisted repeat exam. The AI identifies and scores thyroid nodules, and the study looks at whether this extra information leads to additional biopsies or changes in the surgical plan. The goal is to see if AI can improve diagnostic accuracy and treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-assisted ultrasound system used as a second-read tool before thyroid surgery
What this could lead to
If effective, this AI tool could help surgeons make more accurate decisions about thyroid surgery, potentially reducing unnecessary procedures and improving outcomes.
What could go wrong
This is a single-center study, and the AI system only evaluates thyroid nodules, not lymph nodes. Its benefit may be limited, and results may not generalize to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

515 people

The number who actually took part.

Started

Sep 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with preoperative pathological confirmation of thyroid malignant tumors undergoing surgical treatment. * Patients with benign thyroid tumors, such as thyroid adenomas causing compressive symptoms, undergoing surgical treatment. * Patients with complete and high-quality traditional two-dimensional color ultrasound images. * Complete postoperative pathology reports. * Willingness to participate in this clinical trial and signing of informed consent. Exclusion Criteria: * Patients with a history of neck surgery or radiotherapy. * Patients with a history of malignant tumors in other parts of the body. * Patients with thyroid dysfunction. * Incomplete or poor-quality traditional two-dimensional color ultrasound images. * Incomplete postoperative pathology reports. * Refusal to participate in this clinical trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign thyroid tumor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign thyroid gland neoplasm thyroid cancer Thyroid Neoplasms Thyroid Nodule

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Thyroid cancer Thyroid nodule

Contacts and locations

Locations

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, 350001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.